Irène Teyssandier

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Nicole Casadevall, J Nataf, B Viron et al. · New England Journal of Medicine · 2002 · 1.2K citations

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

Sabrina Dupont, Aline Massé, Chloé James et al. · Blood · 2007 · 184 citations

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera

Valérie Ugo, Christophe Marzac, Irène Teyssandier et al. · Experimental Hematology · 2004 · 165 citations · Full text

Multiple Signaling Pathways, Polycythemia Vera, Developmental Biology +9

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia

Ruoping Tang, Pierre Hirsch, Fanny Fava et al. · Blood · 2009 · 58 citations · Full text

Flt3 Internal Tandem Duplication and P-Glycoprotein Functionality in 171 Patients with Acute Myeloid Leukemia

Christophe Marzac, Irène Teyssandier, Ors'Anton Calendini et al. · Clinical Cancer Research · 2006 · 23 citations